| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/21/2009 | US20090131320 Peptides modulating the activity of the engrailed transcription factor |
| 05/21/2009 | US20090130762 Activation of HCV-specific T cells |
| 05/21/2009 | US20090130676 Interaction trap systems for detecting protein interactions |
| 05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2059598A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 05/20/2009 | EP1341912B1 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 05/20/2009 | EP1163260B1 Process for partitioning of proteins |
| 05/20/2009 | CN101434964A Cholera toxin B subunit and lumbrokinase fusion gene, as well as recombinant vector and host cell including the same |
| 05/20/2009 | CN101434657A Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 05/20/2009 | CN101434656A Preparation and use of OPG-HSP70 fusion protein |
| 05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433713A GnRH-PE mutant fusion protein and uses thereof |
| 05/20/2009 | CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector |
| 05/20/2009 | CN100489101C G-eGFP protein, preparation method, and application |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/20/2009 | CN100488981C Proaerolysin containing protease activation sequences and its uses |
| 05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
| 05/19/2009 | US7534577 Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
| 05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009059422A1 Rotavirus vaccine |
| 05/14/2009 | WO2009042162A3 Compositions and methods for inhibiting interleukin pathways |
| 05/14/2009 | US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same |
| 05/13/2009 | EP2057195A2 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 05/13/2009 | EP1485477B1 Novel type-1 cytokine receptor glm-r |
| 05/13/2009 | EP1485407B1 A mutated immunoglobulin-binding protein |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | CN101432428A Recombinant human interferon-like proteins |
| 05/13/2009 | CN101432023A Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 05/13/2009 | CN101429519A Process for producing recombinant insulin-like growth factor-1(IGF-1) amalgamation protein |
| 05/13/2009 | CN101429252A Anti-bladder cancer target superantigen and preparation method thereof |
| 05/13/2009 | CN101429251A Antineoplastic amalgamation protein, preparation method and uses thereof |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531522 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal |
| 05/12/2009 | US7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/12/2009 | US7531178 Immunoadhesin comprising a glycoprotein VI domain |
| 05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009031834A3 Hybridization method between leucine rich repeat family proteins |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117108 Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody |
| 05/07/2009 | US20090117077 Polyethylene glycol-interferon alpha conjugate |
| 05/07/2009 | CA2805976A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/06/2009 | EP2055780A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 05/06/2009 | EP2055777A2 Methods for producing members of specific binding pairs |
| 05/06/2009 | EP2055718A1 Targeting and tracing of antigens in living cells |
| 05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
| 05/06/2009 | EP2054434A1 Myostatin antagonists |
| 05/06/2009 | EP1976992A4 Methods and compositions for the detection and isolation of ligands |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | CN101426525A Chimeric vaccine antigens against classical swine fever virus |
| 05/06/2009 | CN101423839A Rockfishes chitinase A gene, expression vector containing the same, recombinant strain and use thereof |
| 05/06/2009 | CN101423833A Method for preparing inhibin genetic engineering regulation antigen |
| 05/06/2009 | CN101423555A Membrane penetrating polypeptide for specific inhibition of hepatitis b virus assembly and replication |
| 05/06/2009 | CN101423554A Antivariant streptococcus polypeptide and use thereof and preparation method |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101422606A Livestock Asia I type foot-and-mouth disease virus resistance genetic engineering polypeptide vaccine and preparation method thereof |
| 05/06/2009 | CN100484959C Modified recombinant porcine alpha interferon protein and coding gene and uses thereof |
| 05/06/2009 | CN100484958C Fusion protein containing haman parathyroxin 1-34 and its expression vector |
| 05/05/2009 | US7528245 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7528109 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527796 Constructing recombinant gene encoding immunoglobulin fusion for use in diagnosis, prevention and treatment of equine viral disease; veterinary medicine |
| 05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
| 04/30/2009 | WO2009054754A1 PHINS21 RECOMBINANT PLASMID FOR ENCODING HYBRID PROTEIN WITH HUMAN PROINSULIN, AN Escherichia coli JM109/pHINS21 BACTERIA STRAIN AS A PRODUCER OF HYBRID PROTEIN WITH HUMAN PROINSULIN AND A HUMAN PROINSULIN PRODUCING METHOD |
| 04/30/2009 | WO2009053368A1 Single ifn-beta fused to a mutated igg fc fragment |
| 04/30/2009 | WO2009053358A1 Method for purifying fc-fusion proteins |
| 04/30/2009 | WO2009052628A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | US20090113563 Probe for detecting nuclear receptor agonist or antagonist and method for screening agonist or antagonist to nuclear receptor with the use of the same |
| 04/30/2009 | CA2703482A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/30/2009 | CA2703140A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof |
| 04/30/2009 | CA2702448A1 Method for purifying fc-fusion proteins |
| 04/29/2009 | EP2052713A2 Soluble FcgammaR fusion proteins and methods of use thereof |
| 04/29/2009 | EP2052081A1 Fusion proteins and methods for modulation of immune response |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | CN101421306A Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 04/29/2009 | CN101418047A Antigen-antibody compound crystal and preparation method thereof and antigen epitope |
| 04/29/2009 | CN101418046A TAT protein transduction modified NEP1-40 fusion protein and use thereof |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482283C Novel chimeric CD154 |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524637 Nucleotide sequences coding g protein coupled receptors for identifying compounds block or enhance taste perception; food processing; improving taste of pharmeceuticals |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/23/2009 | WO2009052293A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | WO2009051078A1 Therapeutic gene expression system |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |